[{"AccountsPayableCurrent_0_Q1_USD":70374000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-25446000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":549971000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":32698000.0,"LongTermInvestments_0_Q1_USD":507000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":3479000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-24000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":0.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":19996000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":152000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":249116000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":3273000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":8565000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":5967000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":3249000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-165153000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal_1_Q1_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":9000.0,"EquitySecuritiesFvNiGainLoss_1_Q1_USD":-59079000.0,"EquitySecuritiesFvNiRealizedGainLoss_1_Q1_USD":-59079000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":8513000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":234514000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":21786000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":124922000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.054,"OperatingLeaseRightOfUseAsset_0_Q1_USD":62704000.0,"OperatingLeasePayments_1_Q1_USD":3336000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":3413607000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":65147000.0,"OperatingLeaseLiability_0_Q1_USD":74865000.0,"OperatingLeaseCost_1_Q1_USD":3546000.0,"NumberOfReportableSegments_1_Q1_Segment":1.0,"LeaseCost_1_Q1_USD":4448000.0,"InvestmentIncomeNet_1_Q1_USD":3032000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":76175000.0,"InterestReceivableCurrent_0_Q1_USD":1900000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q1_USD":300000000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":9718000.0,"OtherAssetsNoncurrent_0_Q1_USD":118441000.0,"Goodwill_0_Q1_USD":274671000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":11000000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":21818000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":21786000.0,"LiabilitiesNoncurrent_0_Q1_USD":68626000.0,"LiabilitiesCurrent_0_Q1_USD":257219000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2091463000.0,"InventoryNet_0_Q1_USD":84740000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":8207000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-11388000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-69059000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.98,"CommonStockValue_0_Q1_USD":173000.0,"CommonStockSharesOutstanding_0_Q1_shares":172636000.0,"CommonStockSharesIssued_0_Q1_shares":172636000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":249116000.0,"AssetsCurrent_0_Q1_USD":1160447000.0,"Assets_0_Q1_USD":2091463000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":3478000.0,"AccountsReceivableNetCurrent_0_Q1_USD":224613000.0,"CostsAndExpenses_1_Q1_USD":346869000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q1_USD":0.0,"NetIncomeLoss_1_Q1_USD":-168402000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":52007000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-2367000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-1192000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":13273000.0,"ShareBasedCompensation_1_Q1_USD":33617000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":122249000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":195199000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":25256000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"OperatingIncomeLoss_1_Q1_USD":-112355000.0,"CommonStockSharesAuthorized_0_Q1_shares":250000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":172350000.0,"StockholdersEquity_0_Q1_USD":1765618000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1651640000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":174693000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"VariableLeaseCost_1_Q1_USD":902000.0,"Ticker":"SGEN","CIK":"1060736","name":"SEATTLE GENETICS INC \/WA","OfficialName":"Seagen Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"26523270348.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200430"}]